Reaktion #2186195

ord-f305d20863e0457e9526e40b8db01f2a

Reaktionsgleichung

O=c1oc2cc(N3CCN(CCO)CC3)ccc2cc1-c1nc2ccccc2s1
3-benzothiazol-2-yl-7-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-chromen-2-one
CCN(C(C)C)C(C)C
diisopropylethylamine
Cc1ccc(S(=O)(=O)Cl)cc1
tosyl chloride
COC(=O)Cc1nc2ccccc2s1
desired product
COC(=O)Cc1nc2ccccc2s1
Benzothiazol-2-yl-acetic acid methyl ester

Lösungsmittel

Reaktionsbedingungen

Temperatur
0°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Sonstigeto reach room temperature
  2. 2
    workup.STIRRINGAfter an additional two hours stirring
  3. 3
    Sonstigethe reaction mixture is evaporated
  4. 4
    workup.ADDITIONtreated with 0.2 mL tetrabutylammonium fluoride (1M in THF)
  5. 5
    workup.STIRRINGAfter stirring for 30 minutes
  6. 6
    Sonstigethe solution is evaporated

Vorschrift

10 mg (0.025 mmol) 3-benzothiazol-2-yl-7-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-chromen-2-one are dissolved in 3 mL dichloromethane with 2.5 mg (0.8 eq.) 4-dimethylaminopyridine and 0.013 mL (3 eq.) diisopropylethylamine, and cooled to 0° C. 5.7 mg (1.2 eq.) tosyl chloride are added and the reaction mixture stirred for one hour before being allowed to reach room temperature. After an additional two hours stirring, the reaction mixture is evaporated, the residue taken up in tetrahydrofurane and treated with 0.2 mL tetrabutylammonium fluoride (1M in THF). After stirring for 30 minutes, the solution is evaporated and the desired product obtained as a yellow powder.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07569337B2uspto-grants-2009_08